Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 613

1.

Arylsulfatase A, a genetic modifier of Parkinson's disease, is an α-synuclein chaperone.

Lee JS, Kanai K, Suzuki M, Kim WS, Yoo HS, Fu Y, Kim DK, Jung BC, Choi M, Oh KW, Li Y, Nakatani M, Nakazato T, Sekimoto S, Funayama M, Yoshino H, Kubo SI, Nishioka K, Sakai R, Ueyama M, Mochizuki H, Lee HJ, Sardi SP, Halliday GM, Nagai Y, Lee PH, Hattori N, Lee SJ.

Brain. 2019 Jul 15. pii: awz205. doi: 10.1093/brain/awz205. [Epub ahead of print]

PMID:
31312839
2.

Expression of tyrosine hydroxylase isoforms and phosphorylation at serine 40 in the human nigrostriatal system in Parkinson's disease.

Shehadeh J, Double KL, Murphy KE, Bobrovskaya L, Reyes S, Dunkley PR, Halliday GM, Dickson PW.

Neurobiol Dis. 2019 Jul 2;130:104524. doi: 10.1016/j.nbd.2019.104524. [Epub ahead of print]

PMID:
31276794
3.

Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders.

Werry EL, Bright FM, Piguet O, Ittner LM, Halliday GM, Hodges JR, Kiernan MC, Loy CT, Kril JJ, Kassiou M.

Int J Mol Sci. 2019 Jun 28;20(13). pii: E3161. doi: 10.3390/ijms20133161. Review.

4.

Subtle gait and balance impairments occur in idiopathic rapid eye movement sleep behavior disorder.

Ehgoetz Martens KA, Matar E, Hall JM, Phillips J, Szeto JYY, Gouelle A, Grunstein RR, Halliday GM, Lewis SJG.

Mov Disord. 2019 Jun 26. doi: 10.1002/mds.27780. [Epub ahead of print]

PMID:
31242336
5.

Cellular and regional vulnerability in frontotemporal tauopathies.

Forrest SL, Kril JJ, Halliday GM.

Acta Neuropathol. 2019 Jun 15. doi: 10.1007/s00401-019-02035-7. [Epub ahead of print] Review.

PMID:
31203391
6.

Increased Tau Phosphorylation in Motor Neurons From Clinically Pure Sporadic Amyotrophic Lateral Sclerosis Patients.

Stevens CH, Guthrie NJ, van Roijen M, Halliday GM, Ooi L.

J Neuropathol Exp Neurol. 2019 Jul 1;78(7):605-614. doi: 10.1093/jnen/nlz041.

PMID:
31131395
7.

Von Economo Neurons in Behavioral Variant Frontotemporal Dementia with Underlying Alzheimer's Disease.

Tan RH, Yang Y, McCann H, Shepherd C, Halliday GM.

J Alzheimers Dis. 2019;69(4):963-967. doi: 10.3233/JAD-180900.

PMID:
31104018
8.

Temporal evolution of microglia and α-synuclein accumulation following foetal grafting in Parkinson's disease.

Olanow CW, Savolainen M, Chu Y, Halliday GM, Kordower JH.

Brain. 2019 Jun 1;142(6):1690-1700. doi: 10.1093/brain/awz104.

PMID:
31056668
9.

Impaired Color Discrimination-A Specific Marker of Hallucinations in Lewy Body Disorders.

Matar E, Phillips JR, Ehgoetz Martens KA, Halliday GM, Lewis SJG.

J Geriatr Psychiatry Neurol. 2019 Apr 29:891988719845501. doi: 10.1177/0891988719845501. [Epub ahead of print]

PMID:
31035850
10.

Levels of glial cell line-derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in Parkinson's disease.

Virachit S, Mathews KJ, Cottam V, Werry E, Galli E, Rappou E, Lindholm P, Saarma M, Halliday GM, Shannon Weickert C, Double KL.

Brain Pathol. 2019 Apr 29. doi: 10.1111/bpa.12730. [Epub ahead of print]

PMID:
31033033
11.

Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration.

Forrest SL, Crockford DR, Sizemova A, McCann H, Shepherd CE, McGeachie AB, Affleck AJ, Carew-Jones F, Bartley L, Kwok JB, Kim WS, Jary E, Tan RH, McGinley CV, Piguet O, Hodges JR, Kril JJ, Halliday GM.

Neurology. 2019 May 21;92(21):e2472-e2482. doi: 10.1212/WNL.0000000000007530. Epub 2019 Apr 24.

PMID:
31019099
12.

Heritability and genetic variance of dementia with Lewy bodies.

Guerreiro R, Escott-Price V, Hernandez DG, Kun-Rodrigues C, Ross OA, Orme T, Neto JL, Carmona S, Dehghani N, Eicher JD, Shepherd C, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Dawson T, Rosenthal L, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A; International Parkinson's Disease Genomics Consortium, Stone DJ, Bras J.

Neurobiol Dis. 2019 Jul;127:492-501. doi: 10.1016/j.nbd.2019.04.004. Epub 2019 Apr 3.

PMID:
30953760
13.

Neurocognitive Function and Quality of Life Outcomes in the ONTRAC Study for Skin Cancer Chemoprevention by Nicotinamide.

Martin AJ, Dhillon HM, Vardy JL, Dalziell RA, Choy B, Fernández-Peñas P, Dixon A, Renton C, St George G, Chinniah N, Halliday GM, Damian DL, Chen AC.

Geriatrics (Basel). 2019 Mar 25;4(1). pii: E31. doi: 10.3390/geriatrics4010031.

14.

Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia.

Ahmed RM, Phan K, Highton-Williamson E, Strikwerda-Brown C, Caga J, Ramsey E, Zoing M, Devenney E, Kim WS, Hodges JR, Piguet O, Halliday GM, Kiernan MC.

Ann Clin Transl Neurol. 2019 Jan 31;6(3):486-495. doi: 10.1002/acn3.721. eCollection 2019 Mar.

15.

Dopamine depletion alters macroscopic network dynamics in Parkinson's disease.

Shine JM, Bell PT, Matar E, Poldrack RA, Lewis SJG, Halliday GM, O'Callaghan C.

Brain. 2019 Apr 1;142(4):1024-1034. doi: 10.1093/brain/awz034.

PMID:
30887035
16.

The underacknowledged PPA-ALS: A unique clinicopathologic subtype with strong heritability.

Tan RH, Guennewig B, Dobson-Stone C, Kwok JBJ, Kril JJ, Kiernan MC, Hodges JR, Piguet O, Halliday GM.

Neurology. 2019 Mar 19;92(12):e1354-e1366. doi: 10.1212/WNL.0000000000007146. Epub 2019 Feb 15.

PMID:
30770429
17.

Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD.

Pottier C, Ren Y, Perkerson RB 3rd, Baker M, Jenkins GD, van Blitterswijk M, DeJesus-Hernandez M, van Rooij JGJ, Murray ME, Christopher E, McDonnell SK, Fogarty Z, Batzler A, Tian S, Vicente CT, Matchett B, Karydas AM, Hsiung GR, Seelaar H, Mol MO, Finger EC, Graff C, Öijerstedt L, Neumann M, Heutink P, Synofzik M, Wilke C, Prudlo J, Rizzu P, Simon-Sanchez J, Edbauer D, Roeber S, Diehl-Schmid J, Evers BM, King A, Mesulam MM, Weintraub S, Geula C, Bieniek KF, Petrucelli L, Ahern GL, Reiman EM, Woodruff BK, Caselli RJ, Huey ED, Farlow MR, Grafman J, Mead S, Grinberg LT, Spina S, Grossman M, Irwin DJ, Lee EB, Suh E, Snowden J, Mann D, Ertekin-Taner N, Uitti RJ, Wszolek ZK, Josephs KA, Parisi JE, Knopman DS, Petersen RC, Hodges JR, Piguet O, Geier EG, Yokoyama JS, Rissman RA, Rogaeva E, Keith J, Zinman L, Tartaglia MC, Cairns NJ, Cruchaga C, Ghetti B, Kofler J, Lopez OL, Beach TG, Arzberger T, Herms J, Honig LS, Vonsattel JP, Halliday GM, Kwok JB, White CL 3rd, Gearing M, Glass J, Rollinson S, Pickering-Brown S, Rohrer JD, Trojanowski JQ, Van Deerlin V, Bigio EH, Troakes C, Al-Sarraj S, Asmann Y, Miller BL, Graff-Radford NR, Boeve BF, Seeley WW, Mackenzie IRA, van Swieten JC, Dickson DW, Biernacka JM, Rademakers R.

Acta Neuropathol. 2019 Jun;137(6):879-899. doi: 10.1007/s00401-019-01962-9. Epub 2019 Feb 9.

PMID:
30739198
18.

Heritability in frontotemporal tauopathies.

Forrest SL, Halliday GM, McCann H, McGeachie AB, McGinley CV, Hodges JR, Piguet O, Kwok JB, Spillantini MG, Kril JJ.

Alzheimers Dement (Amst). 2019 Jan 24;11:115-124. doi: 10.1016/j.dadm.2018.12.001. eCollection 2019 Dec.

19.

Nicotinamide for photoprotection and skin cancer chemoprevention: A review of efficacy and safety.

Snaidr VA, Damian DL, Halliday GM.

Exp Dermatol. 2019 Feb;28 Suppl 1:15-22. doi: 10.1111/exd.13819. Review.

PMID:
30698874
20.

Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse lines.

Woerman AL, Oehler A, Kazmi SA, Lee J, Halliday GM, Middleton LT, Gentleman SM, Mordes DA, Spina S, Grinberg LT, Olson SH, Prusiner SB.

Acta Neuropathol. 2019 Mar;137(3):437-454. doi: 10.1007/s00401-019-01959-4. Epub 2019 Jan 28.

PMID:
30690664
21.

Gut-brain axis and the spread of α-synuclein pathology: Vagal highway or dead end?

Breen DP, Halliday GM, Lang AE.

Mov Disord. 2019 Mar;34(3):307-316. doi: 10.1002/mds.27556. Epub 2019 Jan 17. Review.

PMID:
30653258
22.

Brain Banking for Research into Neurodegenerative Disorders and Ageing.

Shepherd CE, Alvendia H, Halliday GM.

Neurosci Bull. 2019 Apr;35(2):283-288. doi: 10.1007/s12264-018-0326-3. Epub 2019 Jan 2. Review.

PMID:
30604281
23.

LRRK2-mediated Rab10 phosphorylation in immune cells from Parkinson's disease patients.

Atashrazm F, Hammond D, Perera G, Bolliger MF, Matar E, Halliday GM, Schüle B, Lewis SJG, Nichols RJ, Dzamko N.

Mov Disord. 2019 Mar;34(3):406-415. doi: 10.1002/mds.27601. Epub 2018 Dec 30.

PMID:
30597610
24.

Predictors of survival and progression in behavioural variant frontotemporal dementia.

Agarwal S, Ahmed RM, D'Mello M, Foxe D, Kaizik C, Kiernan MC, Halliday GM, Piguet O, Hodges JR.

Eur J Neurol. 2019 May;26(5):774-779. doi: 10.1111/ene.13887. Epub 2019 Jan 29.

PMID:
30565360
25.

Brahma deficiency in keratinocytes promotes UV carcinogenesis by accelerating the escape from cell cycle arrest and the formation of DNA photolesions.

Farrell AW, Halliday GM, Lyons JG.

J Dermatol Sci. 2018 Dec;92(3):254-263. doi: 10.1016/j.jdermsci.2018.11.006. Epub 2018 Nov 22.

PMID:
30522882
26.

Altered High Density Lipoprotein Composition in Behavioral Variant Frontotemporal Dementia.

Kim WS, He Y, Phan K, Ahmed RM, Rye KA, Piguet O, Hodges JR, Halliday GM.

Front Neurosci. 2018 Nov 14;12:847. doi: 10.3389/fnins.2018.00847. eCollection 2018.

27.

Deletion of Alzheimer's Disease Risk Gene ABCA7 Alters White Adipose Tissue Development and Leptin Levels.

Bhatia S, Fu Y, Hsiao JT, Halliday GM, Kim WS.

J Alzheimers Dis Rep. 2017 Dec 16;1(1):237-247. doi: 10.3233/ADR-170029.

28.

Apolipoprotein D Upregulation in Alzheimer's Disease but Not Frontotemporal Dementia.

Bhatia S, Kim WS, Shepherd CE, Halliday GM.

J Mol Neurosci. 2019 Jan;67(1):125-132. doi: 10.1007/s12031-018-1217-9. Epub 2018 Nov 22.

29.

A comprehensive screening of copy number variability in dementia with Lewy bodies.

Kun-Rodrigues C, Orme T, Carmona S, Hernandez DG, Ross OA, Eicher JD, Shepherd C, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Dawson T, Rosenthal L, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A, Stone DJ, Guerreiro R, Bras J.

Neurobiol Aging. 2019 Mar;75:223.e1-223.e10. doi: 10.1016/j.neurobiolaging.2018.10.019. Epub 2018 Oct 24.

30.

Reduced glucocerebrosidase activity in monocytes from patients with Parkinson's disease.

Atashrazm F, Hammond D, Perera G, Dobson-Stone C, Mueller N, Pickford R, Kim WS, Kwok JB, Lewis SJG, Halliday GM, Dzamko N.

Sci Rep. 2018 Oct 18;8(1):15446. doi: 10.1038/s41598-018-33921-x.

31.

Impact of small vessel disease on severity of motor and cognitive impairment in Parkinson's disease.

Schwartz RS, Halliday GM, Soh D, Cordato DJ, Kril JJ.

J Clin Neurosci. 2018 Dec;58:70-74. doi: 10.1016/j.jocn.2018.10.029. Epub 2018 Oct 14.

PMID:
30327218
32.

A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers.

Zhang M, Ferrari R, Tartaglia MC, Keith J, Surace EI, Wolf U, Sato C, Grinberg M, Liang Y, Xi Z, Dupont K, McGoldrick P, Weichert A, McKeever PM, Schneider R, McCorkindale MD, Manzoni C, Rademakers R, Graff-Radford NR, Dickson DW, Parisi JE, Boeve BF, Petersen RC, Miller BL, Seeley WW, van Swieten JC, van Rooij J, Pijnenburg Y, van der Zee J, Van Broeckhoven C, Le Ber I, Van Deerlin V, Suh E, Rohrer JD, Mead S, Graff C, Öijerstedt L, Pickering-Brown S, Rollinson S, Rossi G, Tagliavini F, Brooks WS, Dobson-Stone C, Halliday GM, Hodges JR, Piguet O, Binetti G, Benussi L, Ghidoni R, Nacmias B, Sorbi S, Bruni AC, Galimberti D, Scarpini E, Rainero I, Rubino E, Clarimon J, Lleó A, Ruiz A, Hernández I, Pastor P, Diez-Fairen M, Borroni B, Pasquier F, Deramecourt V, Lebouvier T, Perneczky R, Diehl-Schmid J, Grafman J, Huey ED, Mayeux R, Nalls MA, Hernandez D, Singleton A, Momeni P, Zeng Z, Hardy J, Robertson J, Zinman L, Rogaeva E; International FTD-Genomics Consortium (IFGC).

Brain. 2018 Oct 1;141(10):2895-2907. doi: 10.1093/brain/awy238.

33.

A Reduction in Inflammatory Macrophages May Contribute to Skin Cancer Chemoprevention by Nicotinamide.

Minocha R, Martin AJ, Chen AC, Scolyer RA, Lyons JG, McKenzie CA, Madore J, Halliday GM, Damian DL.

J Invest Dermatol. 2019 Feb;139(2):467-469. doi: 10.1016/j.jid.2018.08.018. Epub 2018 Sep 20. No abstract available.

PMID:
30244097
34.

Intrafamilial Phenotypic Variability in the C9orf72 Gene Expansion: 2 Case Studies.

Foxe D, Elan E, Burrell JR, Leslie FVC, Devenney E, Kwok JB, Halliday GM, Hodges JR, Piguet O.

Front Psychol. 2018 Sep 3;9:1615. doi: 10.3389/fpsyg.2018.01615. eCollection 2018.

35.

Nigrostriatal pathology with reduced astrocytes in LRRK2 S910/S935 phosphorylation deficient knockin mice.

Zhao Y, Keshiya S, Atashrazm F, Gao J, Ittner LM, Alessi DR, Halliday GM, Fu Y, Dzamko N.

Neurobiol Dis. 2018 Dec;120:76-87. doi: 10.1016/j.nbd.2018.09.003. Epub 2018 Sep 5.

36.

Reply: Will FTLD-tau work for all when FTDP-17 retires?

Forrest SL, Kril JJ, Halliday GM.

Brain. 2018 Aug 1;141(8):e63. doi: 10.1093/brain/awy179. No abstract available.

PMID:
29947744
37.

Melanoma protective antitumor immunity activated by catalytic DNA.

Cai H, Cho EA, Li Y, Sockler J, Parish CR, Chong BH, Edwards J, Dodds TJ, Ferguson PM, Wilmott JS, Scolyer RA, Halliday GM, Khachigian LM.

Oncogene. 2018 Sep;37(37):5115-5126. doi: 10.1038/s41388-018-0306-0. Epub 2018 May 29.

PMID:
29844573
38.

Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.

Pottier C, Zhou X, Perkerson RB 3rd, Baker M, Jenkins GD, Serie DJ, Ghidoni R, Benussi L, Binetti G, López de Munain A, Zulaica M, Moreno F, Le Ber I, Pasquier F, Hannequin D, Sánchez-Valle R, Antonell A, Lladó A, Parsons TM, Finch NA, Finger EC, Lippa CF, Huey ED, Neumann M, Heutink P, Synofzik M, Wilke C, Rissman RA, Slawek J, Sitek E, Johannsen P, Nielsen JE, Ren Y, van Blitterswijk M, DeJesus-Hernandez M, Christopher E, Murray ME, Bieniek KF, Evers BM, Ferrari C, Rollinson S, Richardson A, Scarpini E, Fumagalli GG, Padovani A, Hardy J, Momeni P, Ferrari R, Frangipane F, Maletta R, Anfossi M, Gallo M, Petrucelli L, Suh E, Lopez OL, Wong TH, van Rooij JGJ, Seelaar H, Mead S, Caselli RJ, Reiman EM, Noel Sabbagh M, Kjolby M, Nykjaer A, Karydas AM, Boxer AL, Grinberg LT, Grafman J, Spina S, Oblak A, Mesulam MM, Weintraub S, Geula C, Hodges JR, Piguet O, Brooks WS, Irwin DJ, Trojanowski JQ, Lee EB, Josephs KA, Parisi JE, Ertekin-Taner N, Knopman DS, Nacmias B, Piaceri I, Bagnoli S, Sorbi S, Gearing M, Glass J, Beach TG, Black SE, Masellis M, Rogaeva E, Vonsattel JP, Honig LS, Kofler J, Bruni AC, Snowden J, Mann D, Pickering-Brown S, Diehl-Schmid J, Winkelmann J, Galimberti D, Graff C, Öijerstedt L, Troakes C, Al-Sarraj S, Cruchaga C, Cairns NJ, Rohrer JD, Halliday GM, Kwok JB, van Swieten JC, White CL 3rd, Ghetti B, Murell JR, Mackenzie IRA, Hsiung GR, Borroni B, Rossi G, Tagliavini F, Wszolek ZK, Petersen RC, Bigio EH, Grossman M, Van Deerlin VM, Seeley WW, Miller BL, Graff-Radford NR, Boeve BF, Dickson DW, Biernacka JM, Rademakers R.

Lancet Neurol. 2018 Jun;17(6):548-558. doi: 10.1016/S1474-4422(18)30126-1. Epub 2018 Apr 30.

39.

Selective Spatiotemporal Vulnerability of Central Nervous System Neurons to Pathologic TAR DNA-Binding Protein 43 in Aged Transgenic Mice.

van Hummel A, Chan G, van der Hoven J, Morsch M, Ippati S, Suh L, Bi M, Asih PR, Lee WS, Butler TA, Przybyla M, Halliday GM, Piguet O, Kiernan MC, Chung RS, Ittner LM, Ke YD.

Am J Pathol. 2018 Jun;188(6):1447-1456. doi: 10.1016/j.ajpath.2018.03.002. Epub 2018 Mar 22.

PMID:
29577934
40.

Lipidomics Analysis of Behavioral Variant Frontotemporal Dementia: A Scope for Biomarker Development.

Kim WS, Jary E, Pickford R, He Y, Ahmed RM, Piguet O, Hodges JR, Halliday GM.

Front Neurol. 2018 Feb 28;9:104. doi: 10.3389/fneur.2018.00104. eCollection 2018.

41.

Region- and Cell-specific Aneuploidy in Brain Aging and Neurodegeneration.

Shepherd CE, Yang Y, Halliday GM.

Neuroscience. 2018 Mar 15;374:326-334. doi: 10.1016/j.neuroscience.2018.01.050. Epub 2018 Feb 9. Review.

42.

Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study.

Guerreiro R, Ross OA, Kun-Rodrigues C, Hernandez DG, Orme T, Eicher JD, Shepherd CE, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A, Stone DJ, Bras J.

Lancet Neurol. 2018 Jan;17(1):64-74. doi: 10.1016/S1474-4422(17)30400-3. Epub 2017 Dec 16.

43.

Enhanced Repair of UV-Induced DNA Damage by 1,25-Dihydroxyvitamin D3 in Skin Is Linked to Pathways that Control Cellular Energy.

Rybchyn MS, De Silva WGM, Sequeira VB, McCarthy BY, Dilley AV, Dixon KM, Halliday GM, Mason RS.

J Invest Dermatol. 2018 May;138(5):1146-1156. doi: 10.1016/j.jid.2017.11.037. Epub 2017 Dec 16.

PMID:
29258892
44.

Aphasia in Progressive Supranuclear Palsy: As Severe as Progressive Non-Fluent Aphasia.

Burrell JR, Ballard KJ, Halliday GM, Hodges JR.

J Alzheimers Dis. 2018;61(2):705-715. doi: 10.3233/JAD-170743.

PMID:
29254097
45.

Lipid Metabolism and Survival Across the Frontotemporal Dementia-Amyotrophic Lateral Sclerosis Spectrum: Relationships to Eating Behavior and Cognition.

Ahmed RM, Highton-Williamson E, Caga J, Thornton N, Ramsey E, Zoing M, Kim WS, Halliday GM, Piguet O, Hodges JR, Farooqi IS, Kiernan MC.

J Alzheimers Dis. 2018;61(2):773-783. doi: 10.3233/JAD-170660.

PMID:
29254092
46.

Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.

Forrest SL, Kril JJ, Stevens CH, Kwok JB, Hallupp M, Kim WS, Huang Y, McGinley CV, Werka H, Kiernan MC, Götz J, Spillantini MG, Hodges JR, Ittner LM, Halliday GM.

Brain. 2018 Feb 1;141(2):521-534. doi: 10.1093/brain/awx328. Erratum in: Brain. 2018 Apr 1;141(4):e30.

47.

Reduced LRRK2 in association with retromer dysfunction in post-mortem brain tissue from LRRK2 mutation carriers.

Zhao Y, Perera G, Takahashi-Fujigasaki J, Mash DC, Vonsattel JPG, Uchino A, Hasegawa K, Jeremy Nichols R, Holton JL, Murayama S, Dzamko N, Halliday GM.

Brain. 2018 Feb 1;141(2):486-495. doi: 10.1093/brain/awx344.

48.

Multiple neuronal pathologies are common in young patients with pathologically proven Frontotemporal lobar degeneration.

Tan RH, Yang Y, Halliday GM.

Neuropathol Appl Neurobiol. 2018 Aug;44(5):522-532. doi: 10.1111/nan.12455. Epub 2018 Jan 3.

PMID:
29215728
49.

Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis.

Tan RH, Yang Y, Kim WS, Dobson-Stone C, Kwok JB, Kiernan MC, Halliday GM.

Acta Neuropathol Commun. 2017 Oct 27;5(1):76. doi: 10.1186/s40478-017-0480-2.

50.

Accumulation of dysfunctional SOD1 protein in Parkinson's disease is not associated with mutations in the SOD1 gene.

Trist BG, Fifita JA, Freckleton SE, Hare DJ, Lewis SJG, Halliday GM, Blair IP, Double KL.

Acta Neuropathol. 2018 Jan;135(1):155-156. doi: 10.1007/s00401-017-1779-6. Epub 2017 Oct 19. No abstract available.

PMID:
29052003

Supplemental Content

Loading ...
Support Center